The efficacy and safety of combined 0.01% atropine and orthokeratology for childhood myopia control: a 2-year randomized clinical trial - Top-Institutions - MDSpire

The efficacy and safety of combined 0.01% atropine and orthokeratology for childhood myopia control: a 2-year randomized clinical trial

  • By

  • Ying Yuan

  • Yuqi Deng

  • Chengcheng Zhu

  • Xinting Liu

  • Wei Zhang

  • Bingru Zheng

  • Xinjie Mao

  • Xiao Yang

  • Bilian Ke

  • April 30, 2026

  • 0 min

Share

Top Institutions in Optometry

Brief introduction explaining scope and methodology.

  • #1

    National University of Singapore (NUS) - Singapore Eye Research Institute
    National University of Singapore (NUS) - Singapore Eye Research Institute

    Singapore

    Key Differentiators

    • Ophthalmology
    • Pediatric Ophthalmology
    • Myopia Research

  • #2

    The Zhongshan Ophthalmic Center, Sun Yat-sen University
    The Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong

    Key Differentiators

    • Ophthalmology
    • Myopia Control
    • Clinical Research

  • #3

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Pediatric Ophthalmology
    • Vision Science

  • #4

    The University of Sydney - Save Sight Institute
    The University of Sydney - Save Sight Institute

    Sydney, NSW

    Key Differentiators

    • Ophthalmology
    • Myopia Research
    • Clinical Trials

  • #5

    The Hong Kong Polytechnic University - Optometry and Vision Science
    The Hong Kong Polytechnic University - Optometry and Vision Science

    Hong Kong

    Key Differentiators

    • Optometry
    • Vision Science
    • Myopia Control

Original Source(s)

The efficacy and safety of combined 0.01% atropine and orthokeratology for childhood myopia control: a 2-year randomized clinical trial

  • by Ying Yuan, Yuqi Deng, Chengcheng Zhu, Xinting Liu, Wei Zhang, Bingru Zheng, Xinjie Mao, Xiao Yang, Bilian Ke

  • April 30, 2026

Related Content

Evaluation of Anterior Segment Measurement Discrepancies Between Sirius Plus and Pentacam AXL

Is Europe Safe from the Myopia Epidemic?

As global myopia rates soar, three landmark meta-analyses examine the European epidemiological landscape

Astigmatism Up After COVID Restrictions

Researchers identified delayed corneal changes in schoolchildren that emerged after myopia rates had already increased during the pandemic.